Editorial - A Broader Role for 5ARIs in Prostate Disease? Existing Evidence and Emerging Benefits
BERKELEY, CA (UroToday.com) - In the online edition of the journal Prostate, Dr. Francesco Montorsi and a group of European colleagues reviewed the expanding use of 5-alpha reductase inhibitors (5ARIs) in prostate diseases.
 | Written by Christopher P. Evans, MD, a Contributing Editor with UroToday. |
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810
Privacy Policy | © 2009 UroToday ® All Rights Reserved |
